Who owns ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1?
- CUSIP Number: 02043qab3
Tip: Access positions for across all investors
Analyze quarterly positions in Alnylam Pharmaceuticals Inc Note 1.000 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alnylam Pharmaceuticals Inc Note 1.000 9/1 stock
Who bought or sold ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ubs Global Asset Management Americas | 75M | $74M | 0% | Dec 2023 |
|
| Readystate Asset Management | 70M | $69M | 90% | Dec 2023 |
|
| Calamos Advisors | 56M | $56M | 0% | Dec 2023 |
|
| Steelhead Partners | 55M | $55B | 0% | Dec 2023 |
|
| Aequim Alternative Investments | 41M | $40M | 35% | Dec 2023 |
|
| Davidson Kempner Capital Management | 35M | $34M | 17% | Dec 2023 |
|
| Wolverine Asset Management | 30M | $30M | 46% | Dec 2023 |
|
| Lazard Asset Management | 30M | $29M | 100% | Dec 2023 |
|
| Zazove Associates | 23M | $23M | 10% | Dec 2023 |
|
| Capstone Investment Advisors | 18M | $17M | 75% | Dec 2023 |
|
| Shenkman Capital Management | 14M | $14B | -10% | Dec 2023 |
|
| CNH Partners | 14M | $13M | 100% | Dec 2023 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13M | $13M | 2% | Dec 2023 |
|
| Citadel Advisors | 12M | $12M | -72% | Dec 2023 |
|
| MacKay Shields | 12M | $12M | -48% | Dec 2023 |
|
| Wellington Management Company | 11M | $11M | 34% | Dec 2023 |
|
| Jane Street | 9.4M | $9.0M | 29% | Dec 2023 |
|
| Bank Of Montreal | 9.4M | $9.3M | 44% | Dec 2023 |
|
| Wells Fargo & Company | 7.6M | $7.5M | 0% | Dec 2023 |
|
| Context Capital Management | 7.0M | $6.9B | 139900% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.0M | $5.9M | 25% | Dec 2023 |
|
| Man Group | 5.4M | $5.3M | 0% | Dec 2023 |
|
| SSI Investment Management | 4.9M | $4.8M | 1% | Dec 2023 |
|
| Credit Suisse | 4.5M | $4.5M | -36% | Dec 2023 |
|
| RWC Asset Management | 3.2M | $3.2M | 0% | Dec 2023 |
|
| Amundi | 3.2M | $3.2M | -17% | Dec 2023 |
|
| Walleye Trading Advisors | 2.5M | $2.5M | 100% | Dec 2023 |
|
| CSS | 2.4M | $2.3M | 100% | Dec 2023 |
|
| Royal Bank of Canada | 2.2M | $2.1M | -24% | Dec 2023 |
|
| Edmond De Rothschild Holding | 1.6M | $1.6M | -35% | Dec 2023 |
|
| Liberty Mutual Group Asset Management | 1.5M | $1.5M | 0% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 1.5M | $1.5M | 100% | Dec 2023 |
|
| Citigroup | 1.3M | $1.2M | 100% | Dec 2023 |
|
| Nicholas Investments Partners | 1.1M | $1.1M | 0% | Dec 2023 |
|
| Aviva | 1.0M | $987k | -67% | Dec 2023 |
|
| Palisade Capital Management | 629k | $620k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 600k | $566k | 0% | Mar 2024 |
|
| Groupama Asset Managment | 600k | $595k | 100% | Dec 2023 |
|
| Calamos Wealth Management | 368k | $365k | -3% | Dec 2023 |
|
| Jpmorgan Chase & Co | 115k | $114k | -78% | Dec 2023 |
|
| Nomura Holdings | 77k | $15M | 14% | Dec 2023 |
|
| Virtus Investment Advisers | 47k | $46k | 100% | Dec 2023 |
|
| Russell Investments | 47k | $47k | 100% | Dec 2023 |
|
| SG Americas Securities | 38k | $3.6M | -22% | Dec 2023 |
|
| EverSource Wealth Advisors | 3.0k | $3.0k | 100% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 700.00 | $694k | 100% | Dec 2023 |
|
Who sold out of Alnylam Pharmaceuticals Inc Note 1.000 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Polar Securities | Sep 2023 | 35M | $33M |
| DeepCurrents Investment Group | Sep 2023 | 14M | $13M |
| First Hawaiian Bank | Dec 2023 | 106k | $104k |